BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8655365)

  • 1. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
    Wang CC; Efird J; Nakfoor B; Martins P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes.
    Wang CC
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1143-6. PubMed ID: 3384716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
    Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved local control for advanced oropharyngeal carcinoma following twice daily radiation therapy.
    Wang CC
    Am J Clin Oncol; 1985 Dec; 8(6):512-6. PubMed ID: 4083268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of postradiotherapy neck dissection in supraglottic carcinoma.
    Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
    Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered fractionated radiation therapy for head and neck carcinomas--A Massachusetts General Hospital experience.
    Wang CC
    Ann Acad Med Singap; 1996 May; 25(3):335-40. PubMed ID: 8876897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.